BNP Paribas Index/Partizip. Zert .../ DE0005437461 /
02/05/2024 13:20:44 | Diferencia+0.570 | Bid13:56:46 | Ask- | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
115.300EUR | +0.50% | 115.140 Volumen de oferta: 5,000 |
- Tamaño/ Volumen/ Formato de Ask: - |
Swiss Market Index S... | - CHF | 31/12/2078 | Call |
Newsfile Corp
13:36
PlasCred Circular Innovations Inc. kündigt strategische Vereinbarung über Wachstumskapital mit Nimbu...
GlobeNewswire
13:31
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM...
GlobeNewswire
13:30
Guangzhou Bio-gene Technologies Announces Initiation of Phase I Clinical Trial for BG1805, a CAR-T T...
GlobeNewswire
13:30
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
GlobeNewswire
13:30
GURU Organic Energy Enters Zero Sugar Segment With Metabolism-Boosting GURU Zero Wild Berry
GlobeNewswire
13:30
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
13:30
Clubhouse Media Group, Inc. Announces HoneyDrip.com Growth Results For April 2024
GlobeNewswire
13:30
FuelCell Energy and Toyota Motor North America Celebrate Launch of World's First "Tri-gen" Productio...
GlobeNewswire
13:30
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Upd...
GlobeNewswire
13:30
The 2024 Xos SV Stepvan Now Available for Incentives on the HVIP Vehicle Catalog
GlobeNewswire
13:30
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (s...
GlobeNewswire
13:30
Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, ...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página